The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

References

• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
   PubMed Web of Science ®Google Scholar
• Sibai BM. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med 2000;9:62–5
   PubMedGoogle Scholar
• Garner PR, D'Alton ME, Dudley DK, et al. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990;163:505–8
   PubMed Web of Science ®Google Scholar
• Howarth C, Gazis A, James D. Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med 2007;24:1229–34
   PubMed Web of Science ®Google Scholar
• Hanson U, Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998;77:620–4
   PubMed Web of Science ®Google Scholar
• Jensen DM, Damm P, Ovesen P, et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care 2010;33:90–4
   PubMed Web of Science ®Google Scholar
• Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24:1739–44
   PubMed Web of Science ®Google Scholar
• Combs CA, Rosenn B, Kitzmiller JL, et al. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993;82:802–7
   PubMed Web of Science ®Google Scholar
• Price JH, Hadden DR, Archer DB, et al. Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 1984;91:11–17
   PubMedGoogle Scholar
• Hiilesmaa V, Suhonen L, Teramo K. Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 2000;43:1534–9
   PubMed Web of Science ®Google Scholar
• Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:364–9
   PubMed Web of Science ®Google Scholar
• Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetes. Diabet Med 2002;19:482–9
   PubMed Web of Science ®Google Scholar
• Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011;34:1683–8
   PubMed Web of Science ®Google Scholar
• Temple RC, Aldridge V, Stanley K, et al. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG 2006;113:1329–32
   PubMed Web of Science ®Google Scholar
• Hsu CD, Hong SF, Nickless NA, Copel JA. Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia. Am J Perinatol 1998;15:199–202
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010;5:e13263
   PubMed Web of Science ®Google Scholar
• Yu Y, Jenkins AJ, Nankervis AJ, et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia 2009;52:160–8
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159–67
   PubMed Web of Science ®Google Scholar
• Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701–5
   PubMed Web of Science ®Google Scholar
• Wothe D, Gaziano E, Sunderji S, et al. Measurement of sVEGF R1 and PlGF in serum: comparing prototype assays from Beckman Coulter, Inc. to R&D Systems microplate assays. Hypertens Pregnancy 2011;30:18–27
   PubMed Web of Science ®Google Scholar
• Sunderji S, Gaziano E, Wothe D, et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 2010;202:40 e1–7
   Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911–19
   PubMed Web of Science ®Google Scholar
• Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6
   PubMedGoogle Scholar
• Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 2009;32:2005–9
   PubMed Web of Science ®Google Scholar
• Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339:667–71
   PubMed Web of Science ®Google Scholar
• Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123:2856–69
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021–38
   PubMed Web of Science ®Google Scholar
• McElrath TF, Lim KH, Pare E, et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 2012;207:407 e1–7
   Web of Science ®Google Scholar
• Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012;119:1234–42
   PubMed Web of Science ®Google Scholar
• Signore C, Mills JL, Qian C, et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol 2006;108:338–44
   PubMed Web of Science ®Google Scholar
• Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995;172:642–8
   PubMed Web of Science ®Google Scholar
• Lovestam-Adrian M, Agardh CD, Aberg A, Agardh E. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients. Diabet Med 1997;14:1059–65
   PubMed Web of Science ®Google Scholar
• Ogge G, Romero R, Kusanovic JP, et al. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice. J Matern Fetal Neonatal Med 2010;23:820–7
   PubMed Web of Science ®Google Scholar